Showing results (11-20 of 30) with videos related to
Sort By:
Pageof 3
Medical Hypotheses|January 20, 2007
Is lipid lowering treatment aiming for very low LDL levels safe in terms of the synthesis of steroid hormones?Mustafa Kanat, Murat Sipahioglu, Huseyin Arinc, et al.Case Reports in Oncology|May 4, 2011
Wernicke's Encephalopathy in Colon CancerBerrin Papila, Ozcan Yildiz, Deniz Tural, et al.Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|March 25, 2014
What is the optimal treatment in clinical stage T3N0M0 rectal cancer?Deniz Tural, Ozcan Yildiz, Olgun Elcin, et al.Biomolecules & Biomedicine|April 9, 2026
Claudin 18.2, IDH1, and neutrophil-to-lymphocyte ratio as prognostic biomarkers in unresectable pancreatic ductal adenocarcinoma receiving first-line chemotherapyEbru Karcı, Ferhat Ozden, Elif Kuzucular, et al.Hepato-Gastroenterology|December 4, 2013
The relation between pathological complete response and clinical outcome in patients with rectal cancerDeniz Tural, Fatih Selcukbiricik, Mehmet Akif Özturk, et al.Medical Oncology (Northwood, London, England)|August 4, 2007
Thymoma with chronic diarrhea: report of two cases and review of the literatureOzcan Yildiz, Mustafa Ozguroglu, Hande Turna, et al.World Journal of Oncology|November 18, 2017
Increasing Role of FDG-PET/CT in Detecting Bone Marrow Metastasis of Solid Tumors in Adults: An Analysis of Ten PatientsFatih Selcukbiricik, Ozcan Yildiz, Sabire Yilmaz, et al.ISRN Oncology|November 16, 2011
Olfactory neuroblastomas: an experience of 24 yearsDeniz Tural, Ozcan Yildiz, Fatih Selcukbiricik, et al.Medical Oncology (Northwood, London, England)|August 4, 2007
Paraneoplastic pemphigus associated with fludarabine useOzcan Yildiz, Mustafa Ozguroglu, M Teoman Yanmaz, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|August 21, 2018
Anti-Ri-associated paraneoplastic neurological syndrome: Initial symptom of breast cancer with HER2 overexpression and treatment by dual HER2 blockadeOmer Fatih Olmez, Oguzcan Kinikoglu, Nesrin Helvacı Yilmaz, et al.Pageof 3